1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FBRSL1 CTRPv2 pan-cancer AAC 0.23 9e-10
mRNA FIZ1 CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA ZNF445 CTRPv2 pan-cancer AAC 0.24 1e-09
mRNA PHIP CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA ZNF8 CTRPv2 pan-cancer AAC 0.23 2e-09
mRNA HNRNPA0 CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA FAM117B CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA TFAP4 CTRPv2 pan-cancer AAC 0.23 2e-09
mRNA INTS7 CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA GPC2 CTRPv2 pan-cancer AAC 0.26 2e-09
Download CSV